Cargando…
A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia
Small cell lung cancer (SCLC) is one of the malignant cancers of lung tumors, and hyponatremia, defined as serum sodium concentration (Na(+)) lower than 135 mmol/L, is the most common complication of solid tumors, with an incidence of up to 18.9% and a negative impact on quality of life in SCLC. As...
Autores principales: | Wu, Ranpu, Li, Chuling, Wang, Zimu, Fan, Hang, Song, Yong, Liu, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815354/ https://www.ncbi.nlm.nih.gov/pubmed/33489807 http://dx.doi.org/10.21037/tlcr-20-1147 |
Ejemplares similares
-
A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers
por: Wu, Ranpu, et al.
Publicado: (2021) -
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
por: Wang, Yimin, et al.
Publicado: (2022) -
Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023) -
Metastasis-associated fibroblasts: an emerging target for metastatic cancer
por: Wang, Zimu, et al.
Publicado: (2021) -
A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
por: Wu, Ranpu, et al.
Publicado: (2021)